Loading clinical trials...
Loading clinical trials...
Evaluation of the Addition of Liposomal Bupivacaine to the Erector Spinae Plane (ESP) Block to Multilevel Lumbar Spinal Fusion Surgery
Conditions
Interventions
Liposomal bupivacaine
Bupivacaine
Locations
1
United States
Mount Sinai Hospital
New York, New York, United States
Start Date
August 31, 2022
Primary Completion Date
February 27, 2024
Completion Date
February 27, 2024
Last Updated
May 29, 2024
NCT05029726
NCT04540068
NCT06651775
NCT06615518
NCT07080047
NCT07400068
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions